Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Quaratusugene ozeplasmid by Genprex for Small-Cell Lung Cancer: Likelihood of Approval
Quaratusugene ozeplasmid is under clinical development by Genprex and currently in Phase II for Small-Cell Lung Cancer. According to GlobalData,...